chloroquine and myelin oligodendrocyte glycoprotein (35-55)

chloroquine has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonfanti, AP; Mari, ER; Rasouli, J; Rostami, A; Thome, R; Verinaud, L; Zhang, GX	1

Other Studies

1 other study(ies) available for chloroquine and myelin oligodendrocyte glycoprotein (35-55)

Article	Year
Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity. European journal of immunology, 2018, Volume: 48, Issue:7 Topics: Animals; Autoantigens; Cells, Cultured; Chloroquine; Dendritic Cells; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neutrophils; Peptide Fragments; Signal Transduction; STAT1 Transcription Factor; Th17 Cells	2018

Article

Year

Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity.

European journal of immunology, 2018, Volume: 48, Issue:7

Topics: Animals; Autoantigens; Cells, Cultured; Chloroquine; Dendritic Cells; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neutrophils; Peptide Fragments; Signal Transduction; STAT1 Transcription Factor; Th17 Cells

2018